搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Knowridge
11 小时
Lower doses of blood thinners may reduce bleeding risk
For people taking blood thinners after experiencing a blood clot, a new study suggests that reducing the dose after six ...
News Medical on MSN
8 天
Reduced blood thinner dose may lower bleeding risk and hospital visits
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as ...
8 天
on MSN
Reducing dose of popular blood thinners may limit risk of future bleeding, study finds
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as ...
19 小时
on MSN
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
FierceBiotech
9 天
Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, ...
EurekAlert!
9 天
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests. The ...
BioPharma Dive
8 天
Regeneron says study data support big bet on new blood thinners
The company is planning a “broad Phase 3 program” for two anticoagulants after they outperformed marketed medicines in a pair ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈